Hedge Fund - Berylson Capital Partners
Ascendis Pharma A/S (ASND)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $327,470 | 0.6% | 2,600 | $99.70 |
| 2 | 2023 - Q3 (2023-09-30) | $243,464 | 0.62% | 2,600 | $93.55 |
| 3 | 2023 - Q2 (2023-06-30) | $232,050 | 0.65% | 2,600 | $87.09 |
| 4 | 2023 - Q1 (2023-03-31) | $1,458,192 | 3.66% | 13,600 | $114.40 |
| 5 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $116.10 |
| 6 | 2022 - Q3 (2022-09-30) | $5,266,000 | 8.69% | 51,000 | $94.81 |
| 7 | 2022 - Q2 (2022-06-30) | $0 | 0% | 0 | $94.25 |
| 8 | 2022 - Q1 (2022-03-31) | $4,624,000 | 5.42% | 39,400 | $115.81 |
| 9 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $136.86 |
| 10 | 2021 - Q2 (2021-06-30) | $9,248,000 | 2.04% | 70,300 | $133.25 |
| 11 | 2021 - Q1 (2021-03-31) | $11,899,000 | 2.89% | 92,325 | $151.98 |
| 12 | 2020 - Q4 (2020-12-31) | $12,125,000 | 2.07% | 72,700 | $165.37 |
| 13 | 2020 - Q3 (2020-09-30) | $11,219,000 | 3.92% | 72,700 | $143.74 |
| 14 | 2020 - Q2 (2020-06-30) | $8,608,000 | 5.29% | 58,200 | $137.30 |
| 15 | 2019 - Q2 (2019-06-30) | $0 | 0% | 0 | $119.66 |
| 16 | 2019 - Q1 (2019-03-31) | $977,000 | 1.15% | 8,300 | $87.57 |
The displayed share prices are average quarterly stock market prices.